CD44 and breast carcinoma: In our method, CD44+/CD24− cells were isolated from breast cancer cells (SUM149) by first mixing with anti-CD24-antibody-coated nonmagnetic beads before mixing with anti-CD44-antibody-coated magnetic beads.